|
|
 |
|
Total Number of Holdings (excluding cash): 50
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
3,577 |
$93,955.95 |
2.91% |
| Baxter International Inc. |
BAX |
071813109 |
3,441 |
$90,876.81 |
2.82% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,896 |
$84,452.22 |
2.62% |
| DexCom, Inc. |
DXCM |
252131107 |
921 |
$83,092.62 |
2.57% |
| Olympus Corporation |
7733.JP |
J61240107 |
6,040 |
$82,373.94 |
2.55% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
6,834 |
$81,853.94 |
2.54% |
| Revvity, Inc. |
RVTY |
714046109 |
657 |
$81,553.41 |
2.53% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
229 |
$81,013.33 |
2.51% |
| Agilent Technologies, Inc. |
A |
00846U101 |
513 |
$80,181.90 |
2.48% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
211 |
$79,433.06 |
2.46% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
864 |
$77,993.28 |
2.42% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
255 |
$76,694.08 |
2.38% |
| Waters Corporation |
WAT |
941848103 |
184 |
$74,462.96 |
2.31% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
118 |
$74,050.90 |
2.29% |
| LivaNova Plc |
LIVN |
G5509L101 |
940 |
$73,517.40 |
2.28% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,939 |
$72,162.08 |
2.24% |
| Becton, Dickinson and Company |
BDX |
075887109 |
382 |
$71,670.84 |
2.22% |
| Terumo Corporation |
4543.JP |
J83173104 |
4,460 |
$71,683.07 |
2.22% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
757 |
$68,001.31 |
2.11% |
| Abbott Laboratories |
ABT |
002824100 |
588 |
$67,114.32 |
2.08% |
| Teleflex Incorporated |
TFX |
879369106 |
498 |
$67,210.08 |
2.08% |
| Danaher Corporation |
DHR |
235851102 |
310 |
$66,932.10 |
2.07% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,616 |
$66,744.11 |
2.07% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
295 |
$66,509.28 |
2.06% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
552 |
$65,676.37 |
2.03% |
| The Cooper Companies, Inc. |
COO |
216648501 |
828 |
$63,060.48 |
1.95% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
45 |
$62,695.35 |
1.94% |
| Steris Plc |
STE |
G8473T100 |
265 |
$62,471.10 |
1.94% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
633 |
$62,648.01 |
1.94% |
| Medtronic Plc |
MDT |
G5960L103 |
676 |
$62,394.80 |
1.93% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,332 |
$61,478.75 |
1.90% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
807 |
$59,766.42 |
1.85% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
877 |
$59,518.63 |
1.84% |
| ResMed Inc. |
RMD |
761152107 |
258 |
$58,937.52 |
1.83% |
| Penumbra, Inc. |
PEN |
70975L107 |
178 |
$57,629.28 |
1.79% |
| Stryker Corporation |
SYK |
863667101 |
174 |
$57,019.80 |
1.77% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,073 |
$56,683.94 |
1.76% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
652 |
$55,856.84 |
1.73% |
| Alcon Inc. |
ALC.SW |
H01301128 |
756 |
$55,278.14 |
1.71% |
| Align Technology, Inc. |
ALGN |
016255101 |
340 |
$54,039.60 |
1.67% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
3,516 |
$50,938.73 |
1.58% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
16,500 |
$50,294.42 |
1.56% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
130 |
$48,682.40 |
1.51% |
| BioMerieux |
BIM.FP |
F1149Y232 |
558 |
$48,384.51 |
1.50% |
| Boston Scientific Corporation |
BSX |
101137107 |
955 |
$47,148.35 |
1.46% |
| Cochlear Limited |
COH.AU |
Q25953102 |
484 |
$46,897.35 |
1.45% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$46,195.07 |
1.43% |
| Insulet Corporation |
PODD |
45784P101 |
300 |
$44,061.00 |
1.37% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
514 |
$42,312.48 |
1.31% |
| US Dollar |
$USD |
|
13,864 |
$13,864.22 |
0.43% |
| Yuan Renminbi |
$CNY |
|
1,824 |
$271.27 |
0.01% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|